RICHARDSON, P.; MITSIADES, C.; LAUBACH, J.; CONANT, C.; HIDESHIMA, T.; CHAUHAN, D.; SCHLOSSMAN, R.; GHOBRIAL, I.; MUNSHI, N.; ANDERSON, K. Proteasome inhibitors: beyond NFKB inhibition alone and the emerging role of combination therapy in the treatment of multiple myeloma. Hematology Meeting Reports (formerly Haematologica Reports), [S. l.], v. 2, n. 5, 2009. DOI: 10.4081/hmr.v2i5.753. Disponível em: https://www.pagepress.org/journals/hmr/article/view/753. Acesso em: 22 jul. 2024.